Company Overview

Update
Founded:
1997
Headquarters:
Hayward, CA
Funding:
$534.30M
Categories:
Biotechnology

Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.

Description

Update

Intarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The company’s products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.

Current Team (10)

Update

Board Members and Advisors (4)

Update

Funding Rounds (8) - $534.30M

Update

Investors (10)

Update

Offices/Locations (1)

Update
  • Office

    24650 Industrial Boulevard

    Hayward, CA 94545

    USA